Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy
Background: Cladribine (2-CdA) can cross the blood–brain barrier, resulting in inhibition of DNA synthesis and repair and disruption of cellular proliferation in actively dividing lymphocytes. No data on effect on neurons are available. Aim: To study “in vitro” 2-CdA apoptotic effects on neurons in...
Main Authors: | Maddalena Ruggieri, Concetta Domenica Gargano, Anna Ferretta, Alessia Manni, Antonio Capacchione, Antonio Frigeri, Pietro Iaffaldano, Maria Trojano, Damiano Paolicelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/10/8/548 |
Similar Items
-
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients
by: Damiano Paolicelli, et al.
Published: (2022-11-01) -
Molecular signature associated with cladribine treatment in patients with multiple sclerosis
by: Nicolas Fissolo, et al.
Published: (2023-07-01) -
Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine
by: Leoni Rolfes, et al.
Published: (2023-04-01) -
Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice
by: S. V. Petrov, et al.
Published: (2020-08-01) -
Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists
by: R. Kizlaitienė, et al.
Published: (2024-03-01)